NO973835D0 - Fremgangsmåte for fremstilling av lorakarbefmonohydrat - Google Patents

Fremgangsmåte for fremstilling av lorakarbefmonohydrat

Info

Publication number
NO973835D0
NO973835D0 NO973835A NO973835A NO973835D0 NO 973835 D0 NO973835 D0 NO 973835D0 NO 973835 A NO973835 A NO 973835A NO 973835 A NO973835 A NO 973835A NO 973835 D0 NO973835 D0 NO 973835D0
Authority
NO
Norway
Prior art keywords
preparation
loracarbef monohydrate
loracarbef
monohydrate
Prior art date
Application number
NO973835A
Other languages
English (en)
Other versions
NO973835L (no
NO308471B1 (no
Inventor
William C Henning
Theodore R Stout
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO973835D0 publication Critical patent/NO973835D0/no
Publication of NO973835L publication Critical patent/NO973835L/no
Publication of NO308471B1 publication Critical patent/NO308471B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D463/00Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16Nitrogen atoms
    • C07D463/18Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO973835A 1995-03-01 1997-08-20 FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef NO308471B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/396,948 US5580977A (en) 1995-03-01 1995-03-01 Process for preparing loracarbef monohydrate
PCT/US1996/002586 WO1996026942A1 (en) 1995-03-01 1996-02-28 A process for preparing loracarbef monohydrate

Publications (3)

Publication Number Publication Date
NO973835D0 true NO973835D0 (no) 1997-08-20
NO973835L NO973835L (no) 1997-08-20
NO308471B1 NO308471B1 (no) 2000-09-18

Family

ID=23569249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973835A NO308471B1 (no) 1995-03-01 1997-08-20 FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef

Country Status (28)

Country Link
US (1) US5580977A (no)
EP (1) EP0729959B1 (no)
JP (1) JPH11501032A (no)
KR (1) KR19980702666A (no)
CN (1) CN1061349C (no)
AR (1) AR002709A1 (no)
AT (1) ATE184006T1 (no)
AU (1) AU694639B2 (no)
BR (1) BR9607308A (no)
CA (1) CA2213812A1 (no)
CO (1) CO4700429A1 (no)
CZ (1) CZ272897A3 (no)
DE (1) DE69603995T2 (no)
DK (1) DK0729959T3 (no)
ES (1) ES2135165T3 (no)
GR (1) GR3031947T3 (no)
HU (1) HUP9702151A3 (no)
IL (1) IL117228A (no)
NO (1) NO308471B1 (no)
NZ (1) NZ304534A (no)
PE (1) PE28097A1 (no)
PL (1) PL322111A1 (no)
RU (1) RU2160261C2 (no)
SI (1) SI0729959T1 (no)
TR (1) TR199700877T1 (no)
TW (1) TW330205B (no)
WO (1) WO1996026942A1 (no)
ZA (1) ZA961341B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1130363C (zh) 1997-11-12 2003-12-10 三菱化学株式会社 嘌呤衍生物以及含有其作为有效成分的药物
ATE254616T1 (de) 1999-05-11 2003-12-15 Mitsubishi Chem Corp Dihydrat eines purinderivates, medikamente die dieses als aktiven wirkstoff enthalten und zwischenprodukte zu dessen herstellung
PE20011061A1 (es) 2000-02-01 2001-11-20 Procter & Gamble Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
US6562974B2 (en) 2000-02-01 2003-05-13 The Procter & Gamble Company Process for making geminal bisphosphonates
WO2004046142A1 (en) * 2002-11-21 2004-06-03 Ranbaxy Laboratories Limited Monohydrate solvates of loracarbef

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3531481A (en) * 1969-04-21 1970-09-29 Lilly Co Eli Method for manufacture of crystalline cephalosporin
US3502663A (en) * 1969-04-21 1970-03-24 Lilly Co Eli Crystalline cephalosporin,method for its manufacture
US4775751A (en) * 1985-06-03 1988-10-04 Eli Lilly & Company Process for cephalexin hydrochloride alcoholates
EG18529A (en) * 1987-10-06 1993-04-30 Lilly Co Eli Process for preparing b-lactam hydrate
CA2002596A1 (en) * 1988-11-14 1990-05-14 Thomas M. Eckrich Hydrates of b-lactam antibiotic
US4977257A (en) * 1988-11-14 1990-12-11 Eli Lilly And Company DMF solvates of a β-lactam antibiotic
US5374719A (en) * 1993-06-04 1994-12-20 Eli Lilly And Company Process for converting loracarbef dihydrate to loracarbef monohydrate
US5352782A (en) * 1993-06-04 1994-10-04 Eli Lilly And Company Process for preparing crystalline β-lactam monohydrate
US5399686A (en) * 1993-06-04 1995-03-21 Eli Lilly And Company Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate

Also Published As

Publication number Publication date
PE28097A1 (es) 1997-08-20
CN1061349C (zh) 2001-01-31
CA2213812A1 (en) 1996-09-06
WO1996026942A1 (en) 1996-09-06
ZA961341B (en) 1997-08-20
MX9706606A (es) 1997-11-29
SI0729959T1 (en) 1999-12-31
ES2135165T3 (es) 1999-10-16
IL117228A (en) 2000-12-06
EP0729959A1 (en) 1996-09-04
CO4700429A1 (es) 1998-12-29
AU5174296A (en) 1996-09-18
US5580977A (en) 1996-12-03
IL117228A0 (en) 1996-06-18
JPH11501032A (ja) 1999-01-26
EP0729959B1 (en) 1999-09-01
TW330205B (en) 1998-04-21
DK0729959T3 (da) 1999-12-13
CZ272897A3 (cs) 1998-01-14
AU694639B2 (en) 1998-07-23
BR9607308A (pt) 1997-11-25
HUP9702151A3 (en) 2001-01-29
NO973835L (no) 1997-08-20
AR002709A1 (es) 1998-04-29
DE69603995T2 (de) 2000-01-20
GR3031947T3 (en) 2000-03-31
NO308471B1 (no) 2000-09-18
CN1182429A (zh) 1998-05-20
RU2160261C2 (ru) 2000-12-10
PL322111A1 (en) 1998-01-05
NZ304534A (en) 1998-09-24
DE69603995D1 (de) 1999-10-07
ATE184006T1 (de) 1999-09-15
HUP9702151A2 (hu) 1998-07-28
TR199700877T1 (xx) 1998-02-21
KR19980702666A (ko) 1998-08-05

Similar Documents

Publication Publication Date Title
NO981800L (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
FI960278A (fi) Anataasititaanidioksidin valmistusmenetelmä
NO970212L (no) Fremgangsmåte for fremstilling av enantiomerene av O-demetyltramadol
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
NO973835L (no) Fremgangsmåte for fremstilling av lorakarbefmonohydrat
NO996432D0 (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO179244C (no) Fremgangsmåte for kontinuerlig fremstilling av dimetoksyetanal
NO955082L (no) Fremgangsmåte for fremstilling av glutardialdehyd
NO963432D0 (no) Fremgangsmåte for fremstilling av dimetyldiklorsilan
NO982503D0 (no) FremgangsmÕte ved fremstilling av dioksoazabicykloheksaner
ITRM960874A0 (it) Procedimento migliorato per la produzione di 5-idrossimetiltiazolo
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO974747D0 (no) Fremgangsmåte for fremstilling av streptograminer
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO942381L (no) Fremgangsmåte for fremstilling av indoler
FI973341A0 (fi) Menetelmä organosilaanien valmistamiseksi
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO961004D0 (no) Fremgangsmåte for fremstilling av N-acetyl-D-glukosamin-deacetylase
NO953459L (no) Fremgangsmåte ved fremstilling av cykloheptimidazolderivater
FI960790A (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler
NO963174D0 (no) Fremgangsmåte for fremstilling av isovanillin

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002